Imetelstat Scores Positive ODAC Nod Thanks To Quality Of Life Improvement

Responders to Geron’s proposed anemia treatment could see weeks-long breaks between transfusions, which Oncologic Drugs Advisory Committee members said outweighed efficacy and safety issues.